Zkusit zdarma
Silk Road Medical, Inc

Silk Road Medical, Inc

SILK
Cena:
 
 
Valuace
100
Růst
38
Zdraví
75

Výsledky Q1 2024

Načítám obsah…
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization.
Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices.
The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
preloader

Prezentace a earnings calls Silk Road Medical, Inc (SILK)

DatumNázevKvartálRok
30.04.2024SILK Q1 2024Q12024
28.02.2024SILK Q4 2023Q42023
10.01.2024SILK J.P. Morgan 42nd Annual Healthcare Conference 2024--
08.11.2023SILK Q3 2023Q32023
01.08.2023SILK Q2 2023Q22023
09.05.2023SILK Q1 2023Q12023
28.02.2023SILK Q4 2022Q42022
11.01.2023SILK JPMorgan Healthcare Conference--
08.11.2022SILK Q3 2022Q32022
26.07.2022SILK Q2 2022Q22022